Osmanovic, Alma
Ranxha, Gresa
Kumpe, Mareike
Müschen, Lars
Binz, Camilla
Wiehler, Flavia
Paracka, Lejla
Körner, Sonja
Kollewe, Katja
Petri, Susanne
Schreiber-Katz, Olivia
Funding for this research was provided by:
German Research Foundation (DFG), PRACTIS – Clinician Scientist Program of Hannover Medical School
Deutsche Gesellschaft für Muskelkranke
Bundesministerium für Bildung und Forschung
German-Israeli Foundation for Scientific Research and Development
EU Joint Programme – Neurodegenerative Disease Research
Hannover Medical School Young Faculty Program for Clinician Scientists
Article History
Received: 19 December 2019
Revised: 14 April 2020
Accepted: 17 April 2020
First Online: 2 May 2020
Compliance with ethical standards
:
: AO received honoraria from the Deutsche Gesellschaft fuer Muskelkranke (DGM e.V.) and Biogen<b>.</b> GR and MK received travel funding from Biogen GmbH<b>.</b> LM, CB, FW and SK report no disclosures<b>.</b> LP received travel grants and/or honoraria for lectures from Allergan, Ipsen, Merz. KK received travel grants and/or honoraria for lectures from Allergan, Biogen, Ipsen, Lilly, Novartis, Merz, Teva. SP received honoraria from Biogen, Cytokinetics, Inc., Desitin Pharma, Novartis, Roche, Teva. OSK received scientific grants, travel grants and/or honoraria from the German Neuromuscular Society (Deutsche Gesellschaft fuer Muskelkranke (DGM e.V.)), Novartis, Biogen, Jain Foundation.
: The study has been approved by the local ethics review board at Hannover Medical School and has, therefore, been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All patients gave their written informed consent before entering the study.